华康医疗
(301235)
| 流通市值：9.80亿 | | | 总市值：20.31亿 |
| 流通股本：5095.20万 | | | 总股本：1.06亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 229,705,391.58 | 1,601,565,426.9 | 1,145,105,818 | 692,998,059.04 |
| 营业收入 | 229,705,391.58 | 1,601,565,426.9 | 1,145,105,818 | 692,998,059.04 |
| 二、营业总成本 | 267,765,573.69 | 1,412,467,504.87 | 1,065,544,396.6 | 667,829,687.01 |
| 营业成本 | 161,993,872.4 | 992,351,698.83 | 743,408,099.19 | 457,628,369.89 |
| 税金及附加 | 2,078,834.42 | 6,437,466.61 | 3,725,166.81 | 2,246,433.62 |
| 销售费用 | 39,120,819.56 | 181,322,358.53 | 127,151,566.68 | 79,168,334.12 |
| 管理费用 | 43,730,331.28 | 147,958,522.91 | 125,777,214.48 | 81,613,203.77 |
| 研发费用 | 16,462,194.83 | 76,714,620.7 | 62,295,379.04 | 47,317,298.87 |
| 财务费用 | 4,379,521.2 | 7,682,837.29 | 3,186,970.4 | -143,953.26 |
| 其中:利息费用 | 4,409,643.08 | 10,376,556.44 | 5,669,762.32 | 2,151,400.04 |
| 其中:利息收入 | 428,440.21 | 3,725,506.22 | 3,234,922.96 | 2,565,327.53 |
| 加:公允价值变动收益 | - | 0 | -5,549,327 | - |
| 加:投资收益 | - | 6,235,727.8 | 11,788,743.93 | 6,239,416.93 |
| 资产处置收益 | 16,451.68 | 313,500.27 | 124,151.8 | 33,646.14 |
| 资产减值损失(新) | -1,361,820.28 | -5,133,983.53 | -4,483,815.64 | -2,138,096.16 |
| 信用减值损失(新) | 4,508,609.13 | -71,668,980.24 | -20,917,241.55 | -8,498,716.56 |
| 其他收益 | 1,417,887.4 | 3,954,136.92 | 1,675,006.86 | 1,371,061.24 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -33,479,054.18 | 122,798,323.25 | 62,198,939.8 | 22,175,683.62 |
| 加:营业外收入 | 190,887.48 | 617,516.43 | 606,436.4 | 102,957.17 |
| 减:营业外支出 | 300,386.14 | 2,342,203.87 | 1,088,999.62 | 850,401.12 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -33,588,552.84 | 121,073,635.81 | 61,716,376.58 | 21,428,239.67 |
| 减:所得税费用 | -1,516,881.91 | 13,743,295.93 | 1,641,994.58 | -1,955,916.29 |
| 六、净利润 | -32,071,670.93 | 107,330,339.88 | 60,074,382 | 23,384,155.96 |
| 持续经营净利润 | -32,071,670.93 | 107,330,339.88 | 60,074,382 | 23,384,155.96 |
| 归属于母公司股东的净利润 | -32,071,670.93 | 107,330,339.88 | 60,074,382 | 23,384,155.96 |
| (一)基本每股收益 | -0.3 | 1.02 | 0.57 | 0.22 |
| (二)稀释每股收益 | -0.3 | 1.02 | 0.57 | 0.22 |
| 九、综合收益总额 | -32,071,670.93 | 107,330,339.88 | 60,074,382 | 23,384,155.96 |
| 归属于母公司股东的综合收益总额 | -32,071,670.93 | 107,330,339.88 | 60,074,382 | 23,384,155.96 |
| 公告日期 | 2024-04-27 | 2024-04-27 | 2023-10-30 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |